{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:29:03Z","timestamp":1792592943169,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.berh.2023.101867","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T02:51:17Z","timestamp":1697251877000},"page":"101867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Relapsing polychondritis: Best Practice &amp; Clinical Rheumatology"],"prefix":"10.1016","volume":"37","author":[{"given":"Phillip","family":"Mertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Kobrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Amara","family":"Ogbonnaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ecem","family":"Sevim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Michet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Ferrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.berh.2023.101867_bib1","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.berh.2023.101867_bib2","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/art.41743","article-title":"Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS","volume":"73","author":"Ferrada","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2023.101867_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.rdc.2013.03.002","article-title":"Relapsing polychondritis","volume":"39","author":"Chopra","year":"2013","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.berh.2023.101867_bib4","series-title":"Rheumatology","first-page":"5","article-title":"Relapsing polychondritis","author":"Hs","year":"2000"},{"key":"10.1016\/j.berh.2023.101867_bib5","series-title":"Arthritis and allied conditions: a text-book of rheumatology","author":"Relapsing Polychondritis","year":"1997"},{"issue":"12","key":"10.1016\/j.berh.2023.101867_bib6","first-page":"2181","article-title":"Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study","volume":"54","author":"Hazra","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2023.101867_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/CLEP.S91439","article-title":"A\u00a0nationwide study of the epidemiology of relapsing polychondritis","volume":"8","author":"Horv\u00e1th","year":"2016","journal-title":"Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.berh.2023.101867_bib8","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1002\/art.39790","article-title":"Relapsing polychondritis can Be characterized by three different clinical phenotypes: analysis of a recent series of 142 patients","volume":"68","author":"Dion","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.berh.2023.101867_bib9","article-title":"Relapsing polychondritis--case series from South India","volume":"28","author":"Ananthakrishna","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2023.101867_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00005792-197605000-00001","article-title":"Relapsing polychondritis: prospective study of 23 patients and a review of the literature","volume":"55","author":"McAdam","year":"1976","journal-title":"Medicine (Baltim)"},{"issue":"5","key":"10.1016\/j.berh.2023.101867_bib11","article-title":"Otitis externa: a practical guide to treatment and prevention","volume":"63","author":"Sander","year":"2001","journal-title":"Am Fam Physician"},{"issue":"12","key":"10.1016\/j.berh.2023.101867_bib12","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1016\/j.amjmed.2016.08.004","article-title":"Leukemia cutis: an atypical case","volume":"129","author":"Coen","year":"2016","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.berh.2023.101867_bib13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2340\/00015555-2012","article-title":"Bilateral auricular involvement: a rare presenting sign of chronic lymphocytic leukemia, and successful treatment with electron beam therapy","volume":"95","author":"Walker","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"12","key":"10.1016\/j.berh.2023.101867_bib14","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1002\/art.39790","article-title":"Relapsing polychondritis can Be characterized by three different clinical phenotypes: analysis of a recent series of 142 patients","volume":"68","author":"Dion","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2023.101867_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102353","article-title":"Tracheobronchial involvement of relapsing polychondritis","volume":"18","author":"de Montmollin","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.berh.2023.101867_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4236\/ojra.2013.32016","article-title":"Larngeal manifestations of relapsing polychondritis","volume":"3","author":"Hamdan","year":"2013","journal-title":"Open J Rheumatol Autoimmune Dis"},{"issue":"6","key":"10.1016\/j.berh.2023.101867_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1726-4901(09)70151-0","article-title":"Laryngotracheal involvement as the initial manifestation of relapsing polychondritis","volume":"68","author":"Chang","year":"2005","journal-title":"J\u00a0Chin Med Assoc. Jun"},{"issue":"2","key":"10.1016\/j.berh.2023.101867_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002255","article-title":"Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients","volume":"8","author":"Khitri","year":"2022","journal-title":"RMD Open"},{"issue":"12","key":"10.1016\/j.berh.2023.101867_bib19","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3899\/jrheum.181456","article-title":"Patient-perceived burden of disease in pediatric relapsing polychondritis","volume":"46","author":"Rimland","year":"2019","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2023.101867_bib20","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.autrev.2010.02.016","article-title":"Relapsing polychondritis: an autoimmune disease with many faces","volume":"9","author":"Lahmer","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.berh.2023.101867_bib21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(86)33695-9","article-title":"Ocular and systemic findings in relapsing polychondritis","volume":"93","author":"Isaak","year":"1986","journal-title":"Ophthalmology"},{"issue":"4\u20135","key":"10.1016\/j.berh.2023.101867_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/08820538.2011.588653","article-title":"Relapsing polychondritis: systemic and ocular manifestations, differential diagnosis, management, and prognosis","volume":"26","author":"Yoo","year":"2011","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"10.1016\/j.berh.2023.101867_bib23","first-page":"583","article-title":"Cardiac involvement in relapsing polychondritis in Japan","volume":"55","author":"Shimizu","year":"2016","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2023.101867_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.7326\/0003-4819-104-1-74","article-title":"Relapsing polychondritis. Survival and predictive role of early disease manifestations","volume":"104","author":"Michet","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.berh.2023.101867_bib25","first-page":"817","article-title":"Multiple cardiovascular involvement in a case of relapsing polychondritis","volume":"54","author":"Sasirekha","year":"2006","journal-title":"J\u00a0Assoc Phys India"},{"issue":"6","key":"10.1016\/j.berh.2023.101867_bib26","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0049-0172(97)80028-5","article-title":"Cardiovascular involvement in relapsing polychondritis","volume":"26","author":"Del Rosso","year":"1997","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2023.101867_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCIMAGING.113.001290","article-title":"Unsuspected cardiovascular involvement in relapsing polychondritis: a case of aortitis with critical coronary artery stenosis secondary to relapsing polychondritis","volume":"7","author":"Sugrue","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.berh.2023.101867_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jbspin.2017.05.009","article-title":"Aortic involvement in relapsing polychondritis","volume":"85","author":"Le Besnerais","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"12","key":"10.1016\/j.berh.2023.101867_bib29","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3899\/jrheum.200083","article-title":"Relapsing polychondritis and large-vessel vasculitis","volume":"47","author":"D'Cruz","year":"2020","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2023.101867_bib30","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00296-019-04468-5","article-title":"Aortic involvement in relapsing polychondritis: case-based review","volume":"41","author":"Erdogan","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2023.101867_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2021.10.007","article-title":"A\u00a0prospective observational cohort study and systematic review of 40 patients with mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome","volume":"52","author":"Luo","year":"2022","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2023.101867_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-200105000-00003","article-title":"Dermatologic manifestations of relapsing polychondritis. A study of 200 cases at a single center","volume":"80","author":"Franc\u00e8s","year":"2001","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.berh.2023.101867_bib33","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/art.41743","article-title":"Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS","volume":"73","author":"Ferrada","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2023.101867_bib34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.7326\/0003-4819-129-2-199807150-00011","article-title":"Relapsing polychondritis","volume":"129","author":"Trentham","year":"1998","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.berh.2023.101867_bib35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00005792-198705000-00004","article-title":"Renal involvement in relapsing polychondritis","volume":"66","author":"Chang-Miller","year":"1987","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.berh.2023.101867_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/00313028809085207","article-title":"IgA nephropathy in relapsing polychondritis","volume":"20","author":"Dalal","year":"1988","journal-title":"Pathology"},{"issue":"6 Pt 1","key":"10.1016\/j.berh.2023.101867_bib37","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1288\/00005537-197906000-00009","article-title":"Relapsing polychondritis--report of ten cases","volume":"89","author":"Damiani","year":"1979","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.berh.2023.101867_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.anl.2005.11.020","article-title":"Otologic manifestations of relapsing polychondritis. Review of literature and report of nine cases","volume":"33","author":"Bachor","year":"2006","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"10.1016\/j.berh.2023.101867_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s40257-016-0226-0","article-title":"Relapsing polychondritis: a review and guide for the dermatologist","volume":"18","author":"Smylie","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"10.1016\/j.berh.2023.101867_bib40","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/art.41270","article-title":"Defining clinical subgroups in relapsing polychondritis: a prospective observational cohort study","volume":"72","author":"Ferrada","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"42","key":"10.1016\/j.berh.2023.101867_bib41","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012837","volume":"97","author":"Shimizu","year":"2018","journal-title":"Medicine (Baltim)"},{"issue":"4","key":"10.1016\/j.berh.2023.101867_bib42","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/jama.2022.24836","article-title":"Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a clinical population","volume":"329","author":"Beck","year":"2023","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.berh.2023.101867_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000788","article-title":"Relapsing polychondritis: state of the art on clinical practice guidelines","volume":"4","author":"Rednic","year":"2018","journal-title":"RMD Open"},{"issue":"9","key":"10.1016\/j.berh.2023.101867_bib44","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archderm.1976.01630330048013","article-title":"Treatment of relapsing polychondritis with dapsone","volume":"112","author":"Barranco","year":"1976","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.berh.2023.101867_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2022-252431","article-title":"Dapsone-induced methaemoglobinaemia in relapsing polychondritis","volume":"15","author":"Yoshida","year":"2022","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.berh.2023.101867_bib46","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41598-021-04493-0","article-title":"Nationwide cross-sectional survey of patients with relapsing polychondritis in 2019 demonstrates reduction of airway involvement compared with that in 2009","volume":"12","author":"Shimizu","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.berh.2023.101867_bib47","first-page":"937","article-title":"Biologics in relapsing polychondritis: a case series","volume":"31","author":"Moulis","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2023.101867_bib48","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.semarthrit.2011.08.006","article-title":"Biologics in relapsing polychondritis: a literature review","volume":"41","author":"Kemta Lekpa","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2023.101867_bib49","first-page":"1413","article-title":"Treatment of relapsing polychondritis with a TNF antagonist","volume":"32","author":"Carter","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2023.101867_bib50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10067-014-2670-7","article-title":"Sustained response to tocilizumab in a patient with relapsing polychondritis with aortic involvement: a case based review","volume":"34","author":"Stael","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2023.101867_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/09273948.2020.1763405","article-title":"Sustained remission with tocilizumab in refractory relapsing polychondritis with ocular involvement: a case series","volume":"29","author":"Farhat","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"10.1016\/j.berh.2023.101867_bib52","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/rheumatology\/keab442","article-title":"Efficacy of tocilizumab for refractory relapsing polychondritis with tracheal stenosis and respiratory distress","volume":"61","author":"Liao","year":"2022","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2023.101867_bib53","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/rheumatology\/kel041","article-title":"Refractory relapsing polychondritis: rapid and sustained response in the treatment with an IL-1 receptor antagonist (anakinra)","volume":"45","author":"Vounotrypidis","year":"2006","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.berh.2023.101867_bib54","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jbspin.2008.02.011","article-title":"Efficacy of anakinra in a patient with refractory relapsing polychondritis","volume":"75","author":"Wendling","year":"2008","journal-title":"Joint Bone Spine"},{"issue":"5","key":"10.1016\/j.berh.2023.101867_bib55","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/rheumatology\/kep436","article-title":"Abatacept for relapsing polychondritis","volume":"49","author":"Moulis","year":"2010","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.berh.2023.101867_bib56","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/art.24366","article-title":"Treatment of relapsing polychondritis with rituximab: a retrospective study of nine patients","volume":"61","author":"Leroux","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2023.101867_bib57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.55563\/clinexprheumatol\/h9gq1o","article-title":"Treatment of relapsing polychondritis: a systematic review","volume":"40","author":"Petitdemange","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2023.101867_bib58","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1378\/chest.116.6.1669","article-title":"Management of airway manifestations of relapsing polychondritis: case reports and review of literature","volume":"116","author":"Sarodia","year":"1999","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.berh.2023.101867_bib59","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/j.athoracsur.2006.02.031","article-title":"Long-term management of polychondritis with serial tracheobronchial stents","volume":"81","author":"Nakajima","year":"2006","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.berh.2023.101867_bib60","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3899\/jrheum.120381","article-title":"Refractory relapsing polychondritis treated with serial success with interleukin 6 receptor blockade","volume":"40","author":"Wallace","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2023.101867_bib61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00405-013-2422-3","article-title":"Clinical analysis of 15 patients with relapsing auricular polychondritis","volume":"271","author":"Yang","year":"2014","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"issue":"9","key":"10.1016\/j.berh.2023.101867_bib62","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s10067-013-2279-2","article-title":"Clinical characteristics and treatment outcomes of patients with relapsing polychondritis with airway involvement","volume":"32","author":"Hong","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"22","key":"10.1016\/j.berh.2023.101867_bib63","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJM197811302992202","article-title":"Antibodies to type II collagen in relapsing polychondritis","volume":"299","author":"Foidart","year":"1978","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.berh.2023.101867_bib64","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00371591","article-title":"Autoantibodies to cartilage collagens in relapsing polychondritis","volume":"285","author":"Yang","year":"1993","journal-title":"Arch Dermatol Res"},{"issue":"8","key":"10.1016\/j.berh.2023.101867_bib65","first-page":"1419","article-title":"Preferential cellular and humoral immune reactivities to native and denatured collagen types IX and XI in a patient with fatal relapsing polychondritis","volume":"20","author":"Alsalameh","year":"1993","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2023.101867_bib66","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/jcp.33.11.1077","article-title":"Anti-collagen antibodies in sera from rheumatoid arthritis patients","volume":"33","author":"Beard","year":"1980","journal-title":"J\u00a0Clin Pathol"},{"issue":"1","key":"10.1016\/j.berh.2023.101867_bib67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.imlet.2015.03.006","article-title":"Anti-type II collagen antibodies detection and avidity in patients with oligoarticular and polyarticular forms of juvenile idiopathic arthritis","volume":"165","author":"Araujo","year":"2015","journal-title":"Immunol Lett"},{"issue":"7","key":"10.1016\/j.berh.2023.101867_bib68","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/RHU.0000000000000438","article-title":"Detection of anti-type II collagen antibodies in patients with chronic gouty arthritis: findings from a pilot study","volume":"22","author":"Kim","year":"2016","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2023.101867_bib69","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/1529-0131(200110)44:10<2402::AID-ART405>3.0.CO;2-L","article-title":"The occurrence of autoantibodies to matrilin 1 reflects a tissue-specific response to cartilage of the respiratory tract in patients with relapsing polychondritis","volume":"44","author":"Hansson","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2023.101867_bib70","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/art.1780380224","article-title":"Serum concentrations of two cartilage matrix proteins reflecting different aspects of cartilage turnover in relapsing polychondritis","volume":"38","author":"Saxne","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2023.101867_bib71","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/art.42072","article-title":"Antibodies to cartilage oligomeric matrix protein are pathogenic in mice and may Be clinically relevant in rheumatoid arthritis","volume":"74","author":"Ge","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2023.101867_bib72","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1002\/art.11281","article-title":"Urinary type II collagen neoepitope as an outcome measure for relapsing polychondritis","volume":"48","author":"Kraus","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2023.101867_bib73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/14397595.2013.852854","article-title":"Serum level of soluble triggering receptor expressed on myeloid cells-1 as a biomarker of disease activity in relapsing polychondritis","volume":"24","author":"Sato","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2023.101867_bib74","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.autrev.2012.06.005","article-title":"The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis","volume":"12","author":"Arnaud","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.berh.2023.101867_bib75","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1007\/s10067-021-05827-z","article-title":"Three new inflammatory markers C reactive protein to albumin ratio, neutrophil to lymphocyte ratio, and platelet to lymphocyte ratio correlated with relapsing polychondritis disease activity index","volume":"40","author":"Cao","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2023.101867_bib76","article-title":"The Relapsing Polychondritis Damage Index (RPDAM): development of a disease-specific damage score for relapsing polychondritis","author":"Mertz","year":"2018","journal-title":"Joint Bone Spine"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694223000530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694223000530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:23:32Z","timestamp":1761499412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694223000530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1521694223000530"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2023.101867","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relapsing polychondritis: Best Practice & Clinical Rheumatology","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2023.101867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101867"}}